An estimated 183 million people worldwide use cannabis.
2018 global sales were $12.2 billion which is an increase of 38%.
2019 global sales are projected to be $16.9 billion.
2022 global sales are projected to be $31.3 billion which is an increase of 26.7%.
According to the ADROIT market research the medical cannabis market will grow at CAGR of 29.3% by 2026.
The synthetic biology market is expected to reach $19.58 Billion by 2022.
Some of the major players in the biosynthetic cannabinoid space are: Ginko Biowroks, Amyris, hyasynth, Librede, Demetrix, Tweewinot, Intrexon, Willow Industries, Vitality Biopharma, TRAIT Biosciences and Octarine Bio.
$12 billion has been invested in the synthetic biology space in the last decade.
$4 billion in 2019 alone.
